VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Feb 19, 2026
Document Date
Feb 18, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Polymeropoulos Mihael Hristos
Copyright © 2005-2026 Vanda Pharmaceuticals Inc. |